Applying sputum as a diagnostic tool in pneumonia: Limited yield, minimal impact on treatment decisions

Chest

Volumn 121, Issue 5, 2002, Pages 1486-1492

  Ewig, Santiago ^a   Schlochtermeier, Matthias ^b   GoÖke, Norbert ^b   Niederman, Michael S ^c  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Dreifaltigkeits Krankenhaus Wesseling   (Germany)

^c WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Antimicrobial treatment; Diagnosis; Gram stain; Outcome; Pneumonia; Sputum

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CANDIDA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ENTEROBACTERIACEAE; EVALUATION; FEMALE; GERMANY; GRAM STAINING; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; PHYSICIAN; PNEUMONIA; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REDUCTION; SAMPLING; SPUTUM ANALYSIS; SPUTUM EXAMINATION;

EID: 0036252627     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.5.1486     Document Type: Article

References (37)

1. Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy
2. Guidelines for the management of community-acquired pneumonia in adults admitted to the hospital
3. Practice guidelines for the management of community-acquired pneumonia in adults
4. Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society
5. Guidelines for the management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, antimicrobial therapy, and prevention
6. European Study on Community-Acquired Pneumonia (ESOCAP) Committee: Guidelines for management of adult community-acquired lower respiratory tract infections
7. Deutsche gesellschaft für pneumologie: Empfehlungen zur therapie der ambulant erworbenen pneumonie
8. Accuracy of Gram's stain in identifying pneumococci in sputum
9. Nonvalue of sputum culture in the management of lower respiratory tract infections
10. Community-acquired pneumonia: The future of the microbiology laboratory; focused diagnosis or syndromic management?
11. Limitations of diagnostic testing in the initial management of patients with community-acquired pneumonia
12. Sputum Gram stain assessment in community-acquired bacteremic pneumonia
13. Community-acquired pneumonia
14. Diagnostic testing to establish a microbial cause is helpful in the management of community-acquired pneumonia
15. Community-acquired pneumonia: Initial management and empirical treatment
16. Management of patients with community-acquired pneumonia in a primary care hospital: A critical evaluation
17. A prediction rule to identify low-risk patients with community-acquired pneumonia
18. Etiology of community-acquired pneumonia: Impact of age, comorbidity, and severity
19. Community acquired pneumonia requiring hospitalisation: 5-year prospective study
20. Community-acquired pneumonia: Aetiology and prognostic index evaluation
21. Aetiology of community acquired pneumonia in Valencia, Spain: A multicentre prospective study
22. Community-acquired pneumonia: Aetiology and usefulness of severity criteria on admission
23. Community acquired pneumonia requiring hospitalization: Is it different in the elderly?
24. Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognosis
25. Community-acquired pneumonia in adults in British hospitals in 1982-1983: A survey of aetiology; mortality, prognostic factors and outcome
26. Evaluation of housestaff physicians' preparation and interpretation of sputum Gram stains for community-acquired pneumonia
27. Sputum Gram's stain in community-acquired pneumococcal pneumonia: A meta-analysis
28. Distal airway bacterial colonisation in healthy subjects and chronic lung diseases: A bronchoscopic study
29. Bacterial infection in chronic obstructive pulmonary disease: A study of stable and exacerbated outpatients using the protected specimen brush
30. Quality of care, process, and outcomes in elderly patients with pneumonia
31. Severe community-acquired pneumonia: Risk factors and follow-up epidemiology
32. The value of routine microbial investigation in community-acquired pneumonia
33. Value of routine microbial investigation in community acquired pneumonia treated in a tertiary care center
34. Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia
35. Nonvalue of the initial microbiological studies in the management of nonsevere community-acquired pneumonia
36. Prospective study of the usefulness of sputum Gram stain in an approach to community-acquired pneumonia requiring hospitalization
37. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia